Caricamento...
Laquinimod, an upcoming oral immunomodulatory agent for treatment of multiple sclerosis
Laquinimod is a novel oral drug that is currently being evaluated for the treatment of relapsing-remitting multiple sclerosis (RRMS). Although the mode of action of laquinimod remains to be fully elucidated, current knowledge indicates laquinimod exerts beneficial activities both on the peripheral i...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4195809/ https://ncbi.nlm.nih.gov/pubmed/24731945 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.expneurol.2014.04.002 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|